ELETRIPTAN
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | ELETRIPTAN |
| DrugBank ID | DB00216 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 41 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| theca steroid-producing cell malignant tumor of ovary, not further specified | TxGNN Knowledge Graph | L5 |
| yolk sac tumor | TxGNN Knowledge Graph | L5 |
| primary non-gestational choriocarcinoma of ovary | TxGNN Knowledge Graph | L5 |
| borderline epithelial tumor of ovary | TxGNN Knowledge Graph | L5 |
| ovarian mucinous adenocarcinoma | TxGNN Knowledge Graph | L5 |
| hereditary site-specific ovarian cancer syndrome | TxGNN Knowledge Graph | L5 |
| ovarian endometrioid adenocarcinoma | TxGNN Knowledge Graph | L5 |
| maligant granulosa cell tumor of ovary | TxGNN Knowledge Graph | L5 |
| ovarian cancer | TxGNN Knowledge Graph | L5 |
| leiomyosarcoma | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11